首页> 外文会议>The Second Asian symposium on pharmaceutical sciences and technology >Preparation and in vivo / in vitro evaluation of a tri-layer tablet containing gimepiride (IR)/metformin (SR) with an isolation layer
【24h】

Preparation and in vivo / in vitro evaluation of a tri-layer tablet containing gimepiride (IR)/metformin (SR) with an isolation layer

机译:含有吉美比利特(IR)/二甲双胍(SR)和隔离层的三层片剂的制备和体内/体外评估

获取原文
获取原文并翻译 | 示例

摘要

Purpose: The objective of the present study was to develop a tri-layer tablet containing gimepiride (IR)/metformin (SR) with an isolation layer which was administered once daily to improve diabetes patients compliance and achieve better glycemic control. Methods: IR (immediate-release) layer, isolation layer and SR (sustained-release) layer were all prepared by wet granulation technique and the trilayer tablets were prepared by trebly compression technology. Results: It was found that the stability of gimepiride was elevated obviously. Metformin hydrochloride in the preparation had sustainedrelease character obviously and the in vivo-in vitro correlation was obvious. Conclusion:The present study successfully prepared a tri-layer tablet which had both IR and SR characters. The preparation is effective in glycemic control rapidly and persistently
机译:目的:本研究的目的是开发一种含有吉美比利特(IR)/二甲双胍(SR)的三层片剂,其隔离层每天给药一次,以改善糖尿病患者的依从性并实现更好的血糖控制。方法:采用湿法制粒制备IR(速释)层,隔离层和SR(缓释)层,采用三重压片技术制备三层片剂。结果:发现吉美必利的稳定性明显提高。该制剂中的盐酸二甲双胍具有明显的缓释特性,体内外相关性明显。结论:本研究成功制备了具有IR和SR特性的三层片剂。该制剂可有效快速地控制血糖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号